Ozempic users say their exes are attempting to reconnect with them after weight loss: Second chance at love
It’s an unexpected Ozempic side effect.Slimmed-down users of GLP-1 drugs say their exes have started sliding into their DMs A recent survey by ZipHealth, which polled 1,000 individuals using Ozempic, Mounjaro and other similar treatments, found that one in five found former flames reaching out to re-connect.
The survey found that women on Ozempic were more likely to experience a blast from the past than male users of the same drug.Meanwhile, nearly one-quarter of single surveyed Ozempic users reported receiving more matches or unsolicited messages on dating apps since starting their GLP-1 regimen.This influx of interest helped one in 10 single users enter a new romantic relationship after shedding some pounds.
These changes convinced nearly half of GLP-1 users that these medications gave them a “second chance” at love.The drugs helped them shed more than just weight — it also helped them shake off shame and anxiety.
Half of those surveyed reported feeling more confident after starting the medication, with women being 12% more likely than men to experience this boost.This confidence extended to all corners of their lives, including the bedroom.
Half of GLP-1 users also found themselves feeling friskier and more adventurous in the bedroom, with one in five even exploring new sexual positions since their weight loss.That’s because they’re not just looking good; they’re feeling good.While people’s weight decreased, their libido increased — 39% of millennials, 37% of Gen Z and 35% of Gen X.
Interestingly, men reported a stronger uptick in libido (40%) than women (35%), although others have complained of having the opposite reaction.Some users experienced a negative impact on their romantic relationships, with one in 10 respondents reporting that their weight loss transformation led to jealousy or insecurity from their partners.
But more often than not, these medications changed people’s relationships for the better.About four in five GLP-1 use...